To provide that compliance with a certain biological opinion is deemed to be compliance with the requirements of the Endangered Species Act of 1973 for purposes of a certain agency action, and for other purposes.

HR9017, introduced on May 22, 2026, and referred to the House Transportation and Infrastructure and Natural Resources committees, aims to deem compliance with a certain biological opinion as satisfying requirements under the Endangered Species Act (ESA) for a particular agency action. The bill's sponsor, Rep. Byron Donalds (R-FL), is a junior member, and the bill has only 4 cosponsors—indicating limited initial momentum. As an authorization bill, it sets policy but does not appropriate funding; any real-world effect depends on subsequent agency implementation. The money trail is indirect: by streamlining ESA consultations, the bill could reduce permitting delays and costs for infrastructure projects covered by the specified biological opinion. However, without knowing which biological opinion or agency action is referenced, the scope remains vague. Structural winners would be companies involved in large-scale infrastructure or transportation projects that frequently require ESA compliance, such as engineering and construction firms (Fluor $FLR, KBR $KBR) and railroads (CSX $CSX). Conversely, environmental consulting firms that rely on ESA compliance work could see reduced demand, but this is speculative. Given the bill is at the referral stage and faces a long path through two committees, floor debate, and potential Senate action, passage in this Congress is uncertain. No real market data for specific stocks was provided, but the bill is currently not a market-moving event.